In football, defense keeps the opposing team in check. A similar strategy is at play inside our cells. Negative feedback ...

by overcoming resistance to PD-1 immunotherapy in triple negative breast cancer patients ... such as the PARP inhibitors. Lab studies suggest that M2, or pro-tumour, macrophages are the culprits ...

Elon Musk faced controversy after accusations of heavy ketamine use during his time in the Trump administration. He responded ...

Los Angeles County public health officials reported 2,399 new cases of the coronavirus, bringing the... Valley activists, ...

A 61-year-old’s fever and cough persist despite dual antibiotics, revealing simultaneous bacterial, viral, and fungal ...

INCY jumps 5.1% on a global QIAGEN deal to develop a companion diagnostic for its mutCALR-targeting cancer therapy.

Researchers at MUSC Hollings Cancer Center are working to pursue better options for people with treatment-resistant cancer.

I’m working to make cancer treatments less painful by developing donor-derived CAR therapies, so others don’t have to suffer ...

Among the top gainers on the Nifty 50 were Power Grid Corp, Cipla, BEL, Bharti Airtel, and Asian Paints. The top movers in ...

This valuable study presents a novel approach to enhance the therapeutic potential of mesenchymal stromal cells (MSCs) by genetically modifying their glycogen synthesis pathway, resulting in increased ...

Discover how training impacts durability in cycling. Learn what sports science says about fatigue resistance, endurance, and ...